Ravi Mehrotra, Chief Medical Officer of Open Health Systems Laboratory(OHSL), shared a post on LinkedIn:
“India’s five-year breast cancer survival rate for women diagnosed during 2017–2021 is 65.7%, significantly lagging behind the global median of 77.8%. This stark disparity – detailed in the groundbreaking Nature Medicine WHO Study – highlights the urgent need for early detection.
The survival rates in high-income countries exceed 87% compared to 66.3% (57.7-73.7%) in the South-East Asia Region.
Possible reasons include:
- Late-Stage Diagnosis: Many patients in India are diagnosed at advanced stages, which drastically reduces treatment efficacy and survival.
- Screening Gaps: A lack of routine screening and widespread awareness results in delayed medical intervention.
- Healthcare Disparities: Access to multimodality treatment, such as timely surgery, radiotherapy, and modern cancer medicines, remains uneven across different regions.”
Title: Global breast cancer survival estimates in 2017-2021 to advance the WHO Global Breast Cancer Initiative
Authors: Fabio Girardi, Mary Nyangasi, Charlton Callender, Marie Ng, Saki Narita, Julie Torode, Heba AlSawahli, Sok King Ong, Freddy Gnangnon, Valerie McCormack, Wael Shelpai, Rizu, Lamia Mahmoud, Haidong Wang, André M. Ilbawi
Read the Full Article.
